Immatics N.V.
IMTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001809196
In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Immatics N.V. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 51 | 2 | 49 | 0 |
| Shares | 22.5M | 79.2K | 23.0M | +634.1K (+2.8%) |
| Value | $292.1M | $1.03M | $309.5M | +$18.4M (+6.3%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Immatics N.V. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 46,303 | $622.0K | 0.01% |
| Gyon Technologies Capital Management, LP | 32,423 | $436.0K | 0.08% |
| Northern Trust Corp | 27,493 | $370.0K | 0.00% |
| Susquehanna International Group, LLP | 23,945 | $322.0K | 0.00% |
| Gsa Capital Partners LLP | 19,817 | $266.0K | 0.03% |
| Cubist Systematic Strategies, LLC | 12,118 | $163.0K | 0.00% |
| Marshall Wace, LLP | 2,982 | $41.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 530 | $7.00K | 0.00% |
Sold out (8)
Institutions that held Immatics N.V. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| AlphaCentric Advisors LLC | 35,000 | $455.0K |
| Millennium Management LLC | 23,927 | $311.0K |
| Virtus ETF Advisers LLC | 17,438 | $227.0K |
| Susquehanna Fundamental Investments, LLC | 15,917 | $207.0K |
| Alpha Paradigm Partners, LLC | 15,909 | $207.0K |
| Two Sigma Investments, LP | 13,067 | $170.0K |
| Belvedere Trading LLC | 3,006 | $40.0K |
| BlackRock Inc. | 1,586 | $21.0K |
Not filed for Q4 2021 yet (2)
Institutions that held Immatics N.V. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 69,188 | $899.0K |
| Copernicus Capital Management, LLC | 10,000 | $130.0K |